Indiana University School of Medicine, Riley CCRC 2641, 705 Riley Hospital Drive, Indianapolis, IN 46202, USA.
Indiana University School of Medicine, Riley CCRC 2623, 705 Riley Hospital Drive, Indianapolis, IN 46202, USA.
J Immunol Res. 2016;2016:4273943. doi: 10.1155/2016/4273943. Epub 2016 Dec 26.
Interplay among immune activation and cancer pathogenesis provides the framework for a novel subspecialty known as immunooncology. In the rapidly evolving field of immunooncology, understanding the tumor-specific immune response enhances understanding of cancer resistance. This review highlights the fundamentals of incorporating precision medicine to discover new immune biomarkers and predictive signatures. Using a personalized approach may have a significant, positive impact on the use of oncolytics to better guide safer and more effective therapies.
免疫激活与癌症发病机制的相互作用为一个新兴的亚专科提供了框架,这个亚专科被称为免疫肿瘤学。在免疫肿瘤学这个快速发展的领域中,对肿瘤特异性免疫反应的理解增强了对癌症耐药性的认识。本文重点介绍了将精准医学纳入发现新的免疫生物标志物和预测性特征的基本原理。采用个性化方法可能会对使用肿瘤溶瘤剂产生重大的积极影响,从而更好地指导更安全、更有效的治疗。